Skip to main content
Clinical Trials/IRCT138807271760N3
IRCT138807271760N3
Completed
Phase 3

Effect of Flutamide and Metformin administered in dieting overweight-obese women with polycystic ovary syndrome

Vice Chancellor for Research and Technology, Babol University of Medical Sciences0 sites80 target enrollmentTBD

Overview

Phase
Phase 3
Intervention
Not specified
Conditions
Polycistic overian syndrome.
Sponsor
Vice Chancellor for Research and Technology, Babol University of Medical Sciences
Enrollment
80
Status
Completed
Last Updated
8 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
8 years ago
Study Type
Interventional
Sex
Female

Investigators

Sponsor
Vice Chancellor for Research and Technology, Babol University of Medical Sciences

Eligibility Criteria

Inclusion Criteria

  • Reproductive age (range 18\-45 yr), body mass index (BMI) at least 28 kg/m2, and waist circumference at least 88 cm, chronic an ovulation severe oligomorrhea or amenorrhea, hirsutism (Ferriman – Gallwey score 8\), total testosterone levels at least 0\.72 ng/ml and polycystic ovarian morphology at ultrasound. Exclusion criteria: Use of any medication or a significant modification in body weight within the previous 3 months or dieting, hyperprolactinemia, cushing’s syndrome, late–onset congenital adrenal hyperplasia, thyroid dysfunction, diabetes, cardiovascular, renal or Liver diseases, positive pregnancy test.

Exclusion Criteria

  • Not provided

Outcomes

Primary Outcomes

Not specified

Similar Trials